semaglutide protocol for weight loss and Type 2 Diabetes GLP-1 Weight Loss in Roseville

2017: the FDA approved semaglutide (Ozempic) for type 2 diabetes the once-weekly molecule that would change everything, with greater A1c reduction and weight loss than its predecessors in the SUSTAIN trial program

[DOI] [PubMed] [Google Scholar] 853.Foltynie T., Aviles-Olmos I

Taking two 7 mg tablets to achieve a 14 mg dose is not recommended

Diabetes Canada recommends screening every 3 years in individuals 40 years of age or those at high risk in order to avoid missing those with undiagnosed dysglycemia, particularly in racial/ethnic minorities

Safety - May be safer than other options due to its unique mechanism

If deemed medically appropriate by one of our partner clinicians, a compounded medication may be prescribed